Not all people with CLL demand therapy. Despite all modern advancements, the iwCLL even now recommends watchful observation for sufferers with asymptomatic disorder.86 This recommendation is based on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Persis… Read More